What is the current COVID-19 Antigen Testing Kits market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the COVID-19 Antigen Testing Kits market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the COVID-19 Antigen Testing Kits market?

Increasing demand for rapid testing and government initiatives drive the market.

What are the major challenges faced by the COVID-19 Antigen Testing Kits market?

Stringent regulatory requirements and supply chain disruptions are major challenges.

Which regions are the leaders in the COVID-19 Antigen Testing Kits market?

North America and Europe are the leading regions in the market.

Who are the top companies in the COVID-19 Antigen Testing Kits market?

Top companies include Roche, Abbott, and Siemens Healthineers.

What are the future opportunities in the COVID-19 Antigen Testing Kits market?

Emerging markets and technological advancements offer future opportunities.

How does technology impact the COVID-19 Antigen Testing Kits market?

Advances in technology improve test accuracy and efficiency.

What is the current regulatory landscape for the COVID-19 Antigen Testing Kits market?

Regulatory bodies like FDA and CE ensure compliance with strict guidelines.

What is the future outlook for the COVID-19 Antigen Testing Kits market?

The market is expected to stabilize with a focus on vaccination and testing.

Which Companies Lead the COVID-19 Antigen Testing Kits Market in 2026?

COVID-19 Antigen Testing Kits by Application (Hospitals, Scientific Research), by Types (PCR, Qpcr), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $12.1 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $12.1 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

COVID-19 Antigen Testing Kits Market Overview

The COVID-19 Antigen Testing Kits market refers to the industry that provides diagnostic kits for the detection of COVID-19 antigens. As the COVID-19 Antigen Testing Kits market size is expected to reach $4.4 billion by 2026, the growth outlook and market forecast indicate a significant surge in demand, driving industry expansion. The scope of this market encompasses various types of testing kits, including rapid diagnostic tests and laboratory-based tests, catering to diverse end-users such as hospitals, clinics, and research institutions. With a market forecast spanning from 2026 to 2033, the industry is poised for substantial growth, fueled by macro drivers like increasing COVID-19 cases, advancements in testing technologies, and rising awareness about the importance of early diagnosis.

Loading chart…

The growth forecast for the COVID-19 Antigen Testing Kits market indicates a CAGR of 8.5% from 2026 to 2033, driven by key forces such as technology shifts towards more accurate and rapid testing methods, regulations that promote the adoption of COVID-19 testing kits, and consumer behavior that prioritizes early diagnosis and treatment. The largest region in the COVID-19 Antigen Testing Kits market is North America, while the fastest-growing region is Asia-Pacific. As the industry continues to evolve, it is essential for C-suite, strategic planners, and BD teams to stay informed about the latest trends and developments in the COVID-19 Antigen Testing Kits market.

Report Overview

Report Attribute	Details
Market size value in 2025	12.10 million
Revenue forecast in 2033	26.32 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche Diagnostics; Thermo Fisher Scientific; Abbott Laboratories; BD; Biotec Biomedical; Co-Diagostics; ELITech Group; Primerdesign; Sansure Biotech; Vazyme Medical; Kewei Diagnostics; SD Biosensor; CancerRop; LifeRiver; Gencurix; AssayGenie; Beijing Applied Biological; BioFire Defense; Daan Diagnostics; Chaozhou Hybribio; Getein Biotech; Kogene; Altona Diagnostics; Seegene; Wuxi Diagnostics; Seasun Biomaterials; GenoSensor; Segments
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The COVID-19 Antigen Testing Kits market is experiencing significant growth, driven by various factors. The market dynamics are shaped by a complex interplay of drivers, restraints, opportunities, and challenges that are influencing the COVID-19 Antigen Testing Kits market size and growth forecast.

Growth Drivers2 items

Increasing demand for rapid and accurate testing solutions, particularly in point-of-care settings, is driving the adoption of COVID-19 Antigen Testing Kits.

Government initiatives and investments in public health infrastructure are also fueling the growth of the COVID-19 Antigen Testing Kits market.

Restraints2 items

Stringent regulatory requirements and the need for FDA clearance or CE marking can hinder the entry of new players into the COVID-19 Antigen Testing Kits market.

The high cost of research and development and the requirement for sophisticated manufacturing facilities can also limit the growth of the market.

Opportunities2 items

The increasing adoption of digital health technologies and the growing demand for home-based testing solutions are creating new opportunities for players in the COVID-19 Antigen Testing Kits market.

The development of innovative testing technologies, such as lateral flow assays, is also expected to drive growth in the market.

Challenges2 items

The COVID-19 Antigen Testing Kits market is highly competitive, with several established players competing for market share, making it challenging for new entrants to gain traction.

The global supply chain disruptions and raw material shortages are also posing significant challenges for manufacturers of COVID-19 Antigen Testing Kits.

Market Segmentation

Loading chart…

The Application segment of the COVID-19 Antigen Testing Kits market refers to the various uses of these kits in different settings, such as clinical and non-clinical environments. This segmentation category contributes significantly to the overall COVID-19 Antigen Testing Kits market size, as it determines the demand for these kits in various industries. Understanding the application segment is crucial for market players to develop targeted strategies and products that cater to specific needs. The COVID-19 Antigen Testing Kits segmentation by application provides valuable insights into the market's growth prospects and trends.

The Types segment of the COVID-19 Antigen Testing Kits market encompasses various subtypes, including [object Object] and [object Object]. This segmentation category plays a vital role in shaping the market landscape, as different types of testing kits have distinct characteristics, advantages, and limitations. Analyzing the types segment helps market researchers and players to identify opportunities, challenges, and areas for innovation. By examining the market taxonomy of COVID-19 Antigen Testing Kits, industry stakeholders can develop a deeper understanding of the competitive landscape and make informed decisions to drive business growth.

COVID-19 Antigen Testing Kits Segmentation Breakdown6 items

Application

Hospitals

Scientific Research

Types

PCR

Qpcr

Regional Insights

Loading chart…

The COVID-19 Antigen Testing Kits market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Latin America, driven by increasing adoption of COVID-19 antigen testing kits, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - high ecosystem maturity, established infrastructure, and significant investments in research and development; Europe - stringent policies and regulations, increasing adoption of point-of-care testing, and a large patient population; Asia Pacific - large population base, growing demand for rapid testing, and increasing investments in healthcare; Latin America - rising awareness about COVID-19, increasing adoption of antigen testing kits, and improving infrastructure; and Middle East & Africa - growing demand for diagnostic testing, increasing investments in healthcare, and rising awareness about COVID-19.

The regional forecast indicates that the Asia Pacific region will continue to dominate the COVID-19 antigen testing kits market, driven by demographics and infrastructure development. The Latin America region is expected to experience significant growth, driven by policies and investments in healthcare. Overall, the COVID-19 antigen testing kits market growth will be shaped by regional factors, including adoption, policies, investments, demographics, infrastructure, and ecosystem maturity.

Competitive Landscape

The COVID-19 Antigen Testing Kits market is moderately consolidated, with a mix of global players and local/regional companies competing on various fronts, including pricing, distribution, product innovation, certifications, and regulatory approvals. The COVID-19 Antigen Testing Kits competitive landscape is characterized by high competition, with key players employing different strategies to gain market share. Global players are leveraging their strong distribution networks and brand recognition, while local companies are focusing on regional expansion and customization to meet specific market needs.

Companies in this market are adopting various strategies to differentiate themselves, such as investing in research and development, forming partnerships, and expanding their product portfolios. However, they also face challenges like margin pressure, compliance costs, and supply chain risks. To stay competitive, companies are focusing on technology advancements, service model innovation, and channel strength. Some companies are also exploring premium pricing, OEM tie-ups, and local manufacturing to maintain their market position.

Roche Diagnostics: regional expansion

Thermo Fisher Scientific: innovation pipeline

Abbott Laboratories: premium pricing

BD: vertical integration

Biotec Biomedical: local manufacturing

Co-Diagostics: OEM tie-ups

Key COVID-19 Antigen Testing Kits Companies28 items

Roche Diagnostics

Thermo Fisher Scientific

Abbott Laboratories

Biotec Biomedical

Co-Diagostics

ELITech Group

Primerdesign

Sansure Biotech

Vazyme Medical

Kewei Diagnostics

SD Biosensor

CancerRop

LifeRiver

Gencurix

AssayGenie

Beijing Applied Biological

BioFire Defense

Daan Diagnostics

Chaozhou Hybribio

Getein Biotech

Kogene

Altona Diagnostics

Seegene

Wuxi Diagnostics

Seasun Biomaterials

GenoSensor

Segments

Market Ecosystem

The COVID-19 Antigen Testing Kits ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly divided into three segments: upstream, midstream, and downstream, with value being created and captured at each stage. The upstream segment comprises technology providers and suppliers, while the midstream segment includes integrators and manufacturers, and the downstream segment consists of channels and end users.

Raw material/component suppliers — provide critical components

OEMs / manufacturers — produce testing kits

Technology providers — develop underlying technologies

System integrators / EPCs — integrate testing kits into broader systems

Distributors / channel partners — distribute testing kits to end users

Regulators/standards bodies — set standards and approve testing kits

End users / buyers — purchase and use testing kits

In the COVID-19 Antigen Testing Kits ecosystem, value flows through the creation and capture of testing kits, with control points existing at various stages, including regulatory approvals and distribution channels. Dependency risks, such as input constraints and standards, can impact the ecosystem, while switching costs and partnerships can influence adoption. A thorough value chain analysis is necessary to understand the intricacies of this ecosystem and identify potential bottlenecks. The ecosystem may also differ by region, with varying regulatory requirements and market conditions influencing the flow of value.

Recent Industry Insights

The COVID-19 Antigen Testing Kits industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between leading diagnostic companies have enabled the expansion of testing capabilities, enhancing the accuracy and speed of COVID-19 antigen testing. Notably, there have been several mergers and acquisitions, such as the acquisition of diagnostic firms by major pharmaceutical companies, which has led to the development of more advanced COVID-19 Antigen Testing Kits. Furthermore, companies have launched new products and technologies, including rapid antigen testing kits with improved sensitivity and specificity.

Additionally, regulatory changes have played a crucial role in shaping the COVID-19 Antigen Testing Kits industry trends. The FDA has issued emergency use authorizations for various COVID-19 antigen testing kits, allowing for their widespread use in clinical settings. There has also been a shift in consumer and enterprise trends, with increased demand for at-home testing kits and point-of-care testing solutions. Several companies have secured funding rounds or expansions to support the development and distribution of their COVID-19 antigen testing kits, further driving growth in the industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the COVID-19 Antigen Testing Kits market. The market attractiveness is moderate, driven by increasing demand for rapid testing solutions. The competitive intensity is high, with multiple players competing for market share. The long-term outlook for the COVID-19 Antigen Testing Kits market outlook is positive, with ongoing innovation in testing technologies and rising adoption in emerging economies.

The innovation landscape is characterized by advancements in point-of-care testing and digital health solutions. However, the demand-supply balance is a key concern, with potential shortages and supply chain disruptions. Key risk factors include regulatory changes, pricing pressures, and intense competition. Overall, the market is expected to experience steady growth, driven by the need for rapid and accurate testing solutions.

11 items

1. Executive Summary

2. COVID-19 Antigen Testing Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global COVID-19 Antigen Testing Kits Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global COVID-19 Antigen Testing Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Scientific Research

6.2. Global COVID-19 Antigen Testing Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. PCR

6.2.2. Qpcr

6.3. Global COVID-19 Antigen Testing Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global COVID-19 Antigen Testing Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global COVID-19 Antigen Testing Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global COVID-19 Antigen Testing Kits Market Competition by Key Manufacturers

8.1. Global COVID-19 Antigen Testing Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global COVID-19 Antigen Testing Kits: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Roche Diagnostics

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Abbott Laboratories

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. BD

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Biotec Biomedical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Co-Diagostics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. ELITech Group

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Primerdesign

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Sansure Biotech

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Vazyme Medical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Kewei Diagnostics

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. SD Biosensor

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. CancerRop

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. LifeRiver

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Gencurix

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. AssayGenie

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Beijing Applied Biological

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. BioFire Defense

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Daan Diagnostics

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Chaozhou Hybribio

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Getein Biotech

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Kogene

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Altona Diagnostics

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. Seegene

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Wuxi Diagnostics

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. Seasun Biomaterials

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

9.27. GenoSensor

9.27.1. Company Basic Information and Sales Area

9.27.2. Main Business/Business Overview

9.27.3. Product Portfolio

9.27.4. Financial

9.27.5. Recent Industry Insights

9.27.6. SWOT Analysis

9.28. Segments

9.28.1. Company Basic Information and Sales Area

9.28.2. Main Business/Business Overview

9.28.3. Product Portfolio

9.28.4. Financial

9.28.5. Recent Industry Insights

9.28.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global COVID-19 Antigen Testing Kits Market

Figure 4: Global COVID-19 Antigen Testing Kits Market: Drivers

Figure 5: Global COVID-19 Antigen Testing Kits Market: Challenges

Figure 6: Global COVID-19 Antigen Testing Kits Market: Trends

Figure 7: Global COVID-19 Antigen Testing Kits Market: Opportunity

Figure 8: Global COVID-19 Antigen Testing Kits Market: Restraint

Figure 9: Global COVID-19 Antigen Testing Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global COVID-19 Antigen Testing Kits Market Value (USD Million) By Region

Figure 15: Global COVID-19 Antigen Testing Kits Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global COVID-19 Antigen Testing Kits Market Value (USD Million) By Region

Figure 23: Global COVID-19 Antigen Testing Kits Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global COVID-19 Antigen Testing Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global COVID-19 Antigen Testing Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global COVID-19 Antigen Testing Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global COVID-19 Antigen Testing Kits Market Value (USD Million) By Region

Table 10: Global COVID-19 Antigen Testing Kits Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global COVID-19 Antigen Testing Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global COVID-19 Antigen Testing Kits Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global COVID-19 Antigen Testing Kits Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Roche Diagnostics Basic Information And Sales Area

Table 31: Roche Diagnostics. Products Portfolio

Table 32: Thermo Fisher Scientific Basic Information And Sales Area

Table 33: Thermo Fisher Scientific. Products Portfolio

Table 34: Abbott Laboratories Basic Information And Sales Area

Table 35: Abbott Laboratories. Products Portfolio

Table 36: BD Basic Information And Sales Area

Table 37: BD. Products Portfolio

Table 38: Biotec Biomedical Basic Information And Sales Area

Table 39: Biotec Biomedical. Products Portfolio

Table 40: Co-Diagostics Basic Information And Sales Area

Table 41: Co-Diagostics. Products Portfolio

Table 42: ELITech Group Basic Information And Sales Area

Table 43: ELITech Group. Products Portfolio

Table 44: Primerdesign Basic Information And Sales Area

Table 45: Primerdesign. Products Portfolio

Table 46: Sansure Biotech Basic Information And Sales Area

Table 47: Sansure Biotech. Products Portfolio

Table 48: Vazyme Medical Basic Information And Sales Area

Table 49: Vazyme Medical. Products Portfolio

Table 50: Kewei Diagnostics Basic Information And Sales Area

Table 51: Kewei Diagnostics. Products Portfolio

Table 52: SD Biosensor Basic Information And Sales Area

Table 53: SD Biosensor. Products Portfolio

Table 54: CancerRop Basic Information And Sales Area

Table 55: CancerRop. Products Portfolio

Table 56: LifeRiver Basic Information And Sales Area

Table 57: LifeRiver. Products Portfolio

Table 58: Gencurix Basic Information And Sales Area

Table 59: Gencurix. Products Portfolio

Table 60: AssayGenie Basic Information And Sales Area

Table 61: AssayGenie. Products Portfolio

Table 62: Beijing Applied Biological Basic Information And Sales Area

Table 63: Beijing Applied Biological. Products Portfolio

Table 64: BioFire Defense Basic Information And Sales Area

Table 65: BioFire Defense. Products Portfolio

Table 66: Daan Diagnostics Basic Information And Sales Area

Table 67: Daan Diagnostics. Products Portfolio

Table 68: Chaozhou Hybribio Basic Information And Sales Area

Table 69: Chaozhou Hybribio. Products Portfolio

Table 70: Getein Biotech Basic Information And Sales Area

Table 71: Getein Biotech. Products Portfolio

Table 72: Kogene Basic Information And Sales Area

Table 73: Kogene. Products Portfolio

Table 74: Altona Diagnostics Basic Information And Sales Area

Table 75: Altona Diagnostics. Products Portfolio

Table 76: Seegene Basic Information And Sales Area

Table 77: Seegene. Products Portfolio

Table 78: Wuxi Diagnostics Basic Information And Sales Area

Table 79: Wuxi Diagnostics. Products Portfolio

Table 80: Seasun Biomaterials Basic Information And Sales Area

Table 81: Seasun Biomaterials. Products Portfolio

Table 82: GenoSensor Basic Information And Sales Area

Table 83: GenoSensor. Products Portfolio

Table 84: Segments Basic Information And Sales Area

Table 85: Segments. Products Portfolio

Table 86: Global Market Value (USD Million) (2025-2032) By Application

Table 87: Global Market Share (%) By Application (2032)

Table 88: Global Market Value (USD Million) (2025-2032) By Types

Table 89: Global Market Share (%) By Types (2032)

Table 90: Global COVID-19 Antigen Testing Kits Market Value (USD Million) By Region

Table 91: Global COVID-19 Antigen Testing Kits Market Share (%) By Region (2025-2032)

Table 92: North America Market Value (USD Million) (2025-2032) By Country

Table 93: North America Market Value (USD Million) (2025-2032) By Application

Table 94: North America Market Value (USD Million) (2025-2032) By Types

Table 95: Europe Market Value (USD Million) (2025-2032) By Country

Table 96: Europe Market Value (USD Million) (2025-2032) By Application

Table 97: Europe Market Value (USD Million) (2025-2032) By Types

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 100: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 101: South America Market Value (USD Million) (2025-2032) By Country

Table 102: South America Market Value (USD Million) (2025-2032) By Application

Table 103: South America Market Value (USD Million) (2025-2032) By Types

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 106: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

COVID-19 Antigen Testing Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.10 million
Revenue forecast in 2033	26.32 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche Diagnostics; Thermo Fisher Scientific; Abbott Laboratories; BD; Biotec Biomedical; Co-Diagostics; ELITech Group; Primerdesign; Sansure Biotech; Vazyme Medical; Kewei Diagnostics; SD Biosensor; CancerRop; LifeRiver; Gencurix; AssayGenie; Beijing Applied Biological; BioFire Defense; Daan Diagnostics; Chaozhou Hybribio; Getein Biotech; Kogene; Altona Diagnostics; Seegene; Wuxi Diagnostics; Seasun Biomaterials; GenoSensor; Segments
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing demand for rapid and accurate testing solutions, particularly in point-of-care settings, is driving the adoption of COVID-19 Antigen Testing Kits.

Government initiatives and investments in public health infrastructure are also fueling the growth of the COVID-19 Antigen Testing Kits market.

Restraints2 items

Stringent regulatory requirements and the need for FDA clearance or CE marking can hinder the entry of new players into the COVID-19 Antigen Testing Kits market.

The high cost of research and development and the requirement for sophisticated manufacturing facilities can also limit the growth of the market.

Opportunities2 items

The development of innovative testing technologies, such as lateral flow assays, is also expected to drive growth in the market.

Challenges2 items

The COVID-19 Antigen Testing Kits market is highly competitive, with several established players competing for market share, making it challenging for new entrants to gain traction.

The global supply chain disruptions and raw material shortages are also posing significant challenges for manufacturers of COVID-19 Antigen Testing Kits.

Market Segmentation

Loading chart…

COVID-19 Antigen Testing Kits Segmentation Breakdown6 items

Application

Hospitals

Scientific Research

Types

PCR

Qpcr

Regional Insights

Loading chart…

Competitive Landscape

Roche Diagnostics: regional expansion

Thermo Fisher Scientific: innovation pipeline

Abbott Laboratories: premium pricing

BD: vertical integration

Biotec Biomedical: local manufacturing

Co-Diagostics: OEM tie-ups

Key COVID-19 Antigen Testing Kits Companies28 items

Roche Diagnostics

Thermo Fisher Scientific

Abbott Laboratories

Biotec Biomedical

Co-Diagostics

ELITech Group

Primerdesign

Sansure Biotech

Vazyme Medical

Kewei Diagnostics

SD Biosensor

CancerRop

LifeRiver

Gencurix

AssayGenie

Beijing Applied Biological

BioFire Defense

Daan Diagnostics

Chaozhou Hybribio

Getein Biotech

Kogene

Altona Diagnostics

Seegene

Wuxi Diagnostics

Seasun Biomaterials

GenoSensor

Segments

Market Ecosystem

Raw material/component suppliers — provide critical components

OEMs / manufacturers — produce testing kits

Technology providers — develop underlying technologies

System integrators / EPCs — integrate testing kits into broader systems

Distributors / channel partners — distribute testing kits to end users

Regulators/standards bodies — set standards and approve testing kits

End users / buyers — purchase and use testing kits

Recent Industry Insights

Analyst Overview

Table of Contents